Influence of intraarticular corticosteroid administration on serum cytokines in rheumatoid arthritis

Clinical Rheumatology

Volumn 26, Issue 5, 2007, Pages 845-848

  Alex, Philip ^a,b   Szodoray, Peter ^a   Arthur, Eugene ^c   Willis, Larry ^c   Hynd, Robert ^c   Flinn, Don ^c   Centola, Michael ^a,b  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF OKLAHOMA   (United States)

^c McBride Clinic   (United States)

Author keywords

Arthritis; Corticosteroid; Cytokines; Intraarticular; Multiplex; Rheumatoid

Indexed keywords

AUTACOID; CORTICOSTEROID; CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 7; METHOTREXATE; MONOCYTE CHEMOTACTIC PROTEIN 1; PREDNISONE; TRIAMCINOLONE ACETONIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD ANALYSIS; CASE REPORT; DISEASE ACTIVITY; DISEASE DURATION; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; FEMALE; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; IMMUNE RESPONSE; IMMUNOASSAY; IMMUNOMODULATION; INFLAMMATION; JOINT SWELLING; MORNING STIFFNESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; TREATMENT FAILURE; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

ADRENAL CORTEX HORMONES; ADULT; ARTHRITIS, RHEUMATOID; CYTOKINES; FEMALE; HUMANS; INJECTIONS, INTRA-ARTICULAR;

EID: 34147124476     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-006-0419-7     Document Type: Article

References (12)

1. Harris E (1983) Glucocorticoid use in rheumatoid arthritis. Hosp Pract (Off Ed) 18(9):137-141, 145-146
2. Cooper C, Kirwan JR (1991) The risks of local and systemic corticosteroid administration. Baillieres Clin Rheumatol 4(2):305-332
3. Gray RG, Tenenbaum J, Gottlieb NL (1981) Local corticosteroid injection treatment in rheumatic disorders. Semin Arthritis Rheum 10(4):231-254
4. Boers M (1998) The case for corticosteroids in the treatment of early rheumatoid arthritis. Rheumatology (Oxford) 38(2):95-97
5. Emkey RD, Lindsay R, Lyssy J, Weisberg JS, Dempster DW, Shen V (1996) The systemic effect of intraarticular administration of corticosteroid on markers of bone formation and bone resorption in patients with rheumatoid arthritis. Arthritis Rheum 39(2):277-282
6. Sharif M, Salisbury C, Taylor DJ, Kirwan JR (1998) Changes in biochemical markers of joint tissue metabolism in a randomized controlled trial of glucocorticoid in early rheumatoid arthritis. Arthritis Rheum 41:1203-1209
7. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31(3):315-324 (Mar)
8. Hitchon CA, Alex P, Erdile LB, Frank MB, Dozmorov I, Tang Y et al (2004) A distinct multicytokine profile is associated with anti-cyclical citrullinated peptide antibodies in patients with early untreated inflammatory arthritis. J Rheumatol 31(12):2336-2346
9. Tsitoura DC, Rothman PB (2004) Enhancement of MEK/ERK signaling promotes glucocorticoid resistance in CD4+ T cells. J Clin Invest 113:619-627
10. Griebel P, Beskorwayne T, Van den Broeke A, Ferrari G (1999) CD40 signaling induces B cell responsiveness to multiple members of the gamma chain-common cytokine family. Int Immunol 11:1139-1147
11. Toraldo G, Roggia C, Qian WP, Pacifici R, Weitzmann MN (2003) IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor kappa B ligand and tumor necrosis factor alpha from T cells. Proc Natl Acad Sci USA 100(1):125-130
12. Kirwan JR (1995) The effect of glucocorticoids on joint destruction in rheumatoid arthritis. The Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group. N Engl J Med 333(3):142-146 (Jul 20)